0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover646.11%IV-665.31%PremiumAug 16, 2024Expiry Date6.52Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6479Delta0.2328Gamma0.15Leverage Ratio-0.0118Theta-0.0029Rho-0.09Eff Leverage0.0009Vega
Reviva Pharmaceuticals Stock Discussion
$3.50 - $4?
don't mind if I do.
$Ambrx Biopharma(AMAM.US)$
The biotech sector faced challenges in the previous year, mainly attributed to high inflation and interest rates, particularly impacting small-cap biotech firms in the difficult fundraising environment of summer 2023.
As a consequence, numerous companies experienced a significant drop in their market caps, with some even falling below the 100 million mark, a rarity...
Dow Jones· 1 min ago
No comment yet